Biotransformation of the sedative 1-(p-chlorophenyl)-2,2-dimethyl-1,3-propanediol 3-carbamate in humans and five animal species.
D000284:Administration, Oral; D000818:Animals; D001673:Biodegradation, Environmental; D001711:Biotransformation; D002219:Carbamates / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D004285:Dogs; D005243:Feces / Q000032:analysis; D005965:Glucuronates / Q000652:urine; D000882:Haplorhini; D006801:Humans; D006868:Hydrolysis; D006993:Hypnotics and Sedatives / Q000652:urine; D008297:Male; D013058:Mass Spectrometry; D010084:Oxidation-Reduction; D011409:Propylene Glycols / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism* / Q000652:urine; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013552:Swine; D013997:Time Factors
D002219:Carbamates; D005965:Glucuronates; D006993:Hypnotics and Sedatives; D011409:Propylene Glycols